Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?
- PMID: 16113422
- DOI: 10.1513/pats.2306029
Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?
Abstract
Our understanding of the pathogenesis and consequences of acute exacerbations of chronic obstructive pulmonary disease (COPD) has increased considerably in the past decade. Several new lines of evidence support bacterial causation of approximately half of the exacerbations in COPD. Acquisition of new strains of bacterial pathogens in patients with COPD is associated with a substantial increase in risk of exacerbation. Bacterial pathogens are isolated in significant concentrations from bronchoscopic samples obtained during acute exacerbation. Neutrophilic airway inflammation is associated with isolation of bacterial pathogens from sputum. A specific immune response to the infecting strains of bacterial pathogens isolated from sputum during exacerbations has been demonstrated. Future work should strive to understand better the host-pathogen interaction that leads to an exacerbation and to develop novel therapeutic and preventive measures.
Similar articles
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
-
Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.Thorax. 2007 Jan;62(1):29-35. doi: 10.1136/thx.2005.056374. Epub 2006 Aug 23. Thorax. 2007. PMID: 16928715 Free PMC article.
-
Pathogenesis of bacterial exacerbations of COPD.COPD. 2006 Jun;3(2):109-15. doi: 10.1080/15412550600651347. COPD. 2006. PMID: 17175674 Review.
-
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.N Engl J Med. 2002 Aug 15;347(7):465-71. doi: 10.1056/NEJMoa012561. N Engl J Med. 2002. PMID: 12181400
-
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7. doi: 10.1164/rccm.200708-1234OC. Epub 2007 Dec 13. Am J Respir Crit Care Med. 2008. PMID: 18079493
Cited by
-
Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples.J Clin Microbiol. 2006 Mar;44(3):923-7. doi: 10.1128/JCM.44.3.923-927.2006. J Clin Microbiol. 2006. PMID: 16517877 Free PMC article.
-
COPD Phenotyping.Respir Care. 2023 Jul;68(7):871-880. doi: 10.4187/respcare.11035. Respir Care. 2023. PMID: 37353326 Free PMC article. Review.
-
Proteases and Their Inhibitors in Chronic Obstructive Pulmonary Disease.J Clin Med. 2018 Aug 28;7(9):244. doi: 10.3390/jcm7090244. J Clin Med. 2018. PMID: 30154365 Free PMC article. Review.
-
Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis.BMJ Open Respir Res. 2019 Sep 17;6(1):e000458. doi: 10.1136/bmjresp-2019-000458. eCollection 2019. BMJ Open Respir Res. 2019. PMID: 31681477 Free PMC article.
-
Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment.Int J Mol Sci. 2023 Feb 17;24(4):4086. doi: 10.3390/ijms24044086. Int J Mol Sci. 2023. PMID: 36835503 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous